NDUFAF7

NDUFAF7 is a mitochondrial matrix S-adenosylmethionine-dependent protein arginine methyltransferase that catalyzes symmetric dimethylation of Arg-85 on the NDUFS2 subunit of respiratory chain complex I, an essential post-translational modification for stabilizing an early ~400 kDa assembly intermediate that nucleates the peripheral arm–membrane arm junction (PMID:24089531, PMID:24838397). Methylation occurs after NDUFS2 incorporates into this subcomplex, and loss of NDUFAF7 triggers AFG3L2-dependent turnover of newly synthesized ND1 and depletion of multiple complex I subunits; a catalytically dead G124V mutant fails to rescue the assembly defect, confirming that methyltransferase activity is required (PMID:24838397). Crystal structures of the Dictyostelium ortholog MidA reveal a catalytic core with regulatory loops that control ligand selection, and methylation weakens NDUFAF7–NDUFS2 binding, providing a substrate-release mechanism conserved from bacteria to humans (PMID:30134162). Germline knockout in mice is embryonic lethal, and the disease-associated D266E missense variant impairs complex I activity and intracellular ATP production (PMID:24838397, PMID:28837730).

1. 2006 Medium

   The initial functional link between NDUFAF7 (MidA) and mitochondrial energy metabolism was established when Dictyostelium knockout showed reduced ATP synthetic capacity without altered oxygen consumption, pointing to a specific complex I defect rather than a global respiratory chain impairment.

   Evidence GFP-tagged MidA localization by fluorescence microscopy; ATP and oxygen consumption measurements in Dictyostelium knockout

   PMID:16507593

   Open questions at the time

   • Single model organism; mechanism unknown
   • No direct complex I activity measurement
   • Methyltransferase function not yet identified
2. 2013 High

   The molecular function of NDUFAF7 was defined: it is an SAM-dependent methyltransferase that symmetrically dimethylates Arg-85 of NDUFS2, placing this modification at the earliest stages of complex I assembly and establishing the first known arginine methylation event in mitochondrial respiratory chain biogenesis.

   Evidence Subcellular fractionation confirming mitochondrial matrix localization; mass spectrometry identification of symmetric dimethylarginine on NDUFS2 Arg-85; in vitro methyltransferase assay

   PMID:24089531

   Open questions at the time

   • Structural basis of substrate recognition unknown
   • Mechanism of substrate release after methylation not determined
   • Consequences of methylation loss on assembly kinetics not fully characterized
3. 2014 High

   The essentiality and specificity of NDUFAF7 catalytic activity were demonstrated across vertebrate systems: loss triggers AFG3L2-dependent degradation of ND1 and destabilizes multiple complex I subunits, while a methyltransferase-dead mutant (G124V) cannot rescue, proving the enzymatic activity—not merely scaffold function—is required for assembly.

   Evidence siRNA knockdown in human fibroblasts; morpholino in zebrafish; germline knockout in mice (embryonic lethal); anti-ND1 immunoprecipitation with mass spectrometry; expression of G124V catalytic mutant

   PMID:24838397

   Open questions at the time

   • Precise stoichiometry and timing of methylation relative to subunit incorporation unknown
   • Whether AFG3L2 surveillance is a direct quality-control response to unmethylated NDUFS2 or an indirect consequence of assembly stalling not resolved
4. 2017 Medium

   A disease-associated missense variant (D266E) was shown to impair complex I activity and ATP production in cultured cells, linking NDUFAF7 dysfunction to human pathology and confirming that subtle perturbation of methyltransferase function is sufficient to compromise bioenergetics.

   Evidence Immunofluorescence, immunoblotting, complex I activity assay, and ATP measurement in cells expressing D266E variant

   PMID:28837730

   Open questions at the time

   • No in vitro methyltransferase reconstitution with D266E mutant protein
   • Structural impact of D266E on enzyme fold not characterized
   • Clinical phenotype–genotype correlation limited to a single study
5. 2018 High

   The structural basis of NDUFAF7 function was elucidated: crystallography of MidA revealed regulatory loops controlling ligand selection and showed that methylation weakens NDUFS2 binding, establishing a product-release mechanism that explains how the enzyme disengages after modifying its substrate during assembly.

   Evidence X-ray crystallography of Dictyostelium MidA; binding assays measuring NDUFS2 affinity before and after methylation; in vivo complementation in Dictyostelium

   PMID:30134162

   Open questions at the time

   • No co-crystal structure with NDUFS2 peptide substrate
   • Kinetic parameters of the human enzyme not reported
   • Role of individual regulatory loops in substrate selectivity not dissected by mutagenesis

• Key open questions include the atomic-resolution mechanism of NDUFS2 recognition by human NDUFAF7, the kinetic parameters of the methylation reaction, whether other mitochondrial substrates exist, and the precise structural defect caused by disease-associated variants.
• No co-crystal structure of human NDUFAF7 with NDUFS2
• No systematic screen for additional methylation substrates in mitochondria
• Genotype–phenotype relationships in patients remain incompletely defined